Antibody production
-
Antibody productionHow advanced monoclonal antibody generation methods are improving conventional envenoming treatments
Philippe Funfrock
Snakebite envenoming has been on WHO’s priority list of neglected tropical diseases since 2017. Due to the complexity and variability of the toxins transmitted by the bite of venomous snakes,…
-
What are the leading monoclonal antibody treatments for cancer?
Arresting cancer progression has evolved from the use of unspecific chemotherapies with serious adverse effects to the adoption of antibody-based… Read More
-
“Cell-based phage display is helping us isolate more biologically relevant antibodies” – Interview with Dr. Mohamed Alfaleh (King Abdulaziz University)
Dr. Mohamed Alfaleh is an assistant professor at King Abdulaziz University (Faculty of Pharmacy, Jeddah, Saudi Arabia). Pharmacist by training,… Read More
-
Can a single amino acid mutation change the course of the COVID-19 pandemic?
Viruses mutate in the course of an epidemic as a result of selective pressure or genetic drift. Resulting mutations may… Read More
-
Essential antibody library generation and display technologies for the discovery of new reagents and biopharmaceuticals
Library generation is a vital first step in any antibody phage display project for therapeutic applications and others. Libraries… Read More
-
Can successful anticancer immunotherapies change the course of the COVID-19 disease?
A recent study revealed the hidden parallelisms in our organism’s response to cancer and COVID-19. Despite the marked differences between… Read More
-
Why phage display for monoclonal antibody production remains an unrivaled technology
Phage display technology revolutionized antibody discovery. By coupling the structural simplicity of phages with the fast replication and high turnover… Read More
-
How to leverage recombinant monoclonal antibody production to increase clinical success rates
Ever since the onset of recombinant technology, therapeutic biologics production has gradually shifted from native to recombinant expression. Today, recombinant… Read More
-
Fundamental and advanced methods to improve monoclonal antibody production in vitro
Ever since the discovery of the hybridoma technology and its inherent limitations, monoclonal antibody production has gradually shifted from hybridoma-based… Read More
-
Will a single COVID-19 drug be enough to treat all patients?
As more and more biotherapeutics enter the early stages of clinical development, scientists are questioning if current approaches will be… Read More
